Platelet Function and Markers of Atherothrombotic Risk in Individuals With Parathyroid Disorders
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf138 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Anda Mihaela Naciu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome 00128, Italy. Hauptthemen laut MEDLINE: Atherosclerosis, Blood Platelets, Hyperparathyroidism, Primary, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Società Italiana dell'Osteoporosi, Italian Ministry of Health, Società Italiana dell’Osteoporosi.
Abstract (Originalsprache)
Context
Both primary hyperparathyroidism (PHPT) and chronic hypoparathyroidism (HypoPT) are associated with the onset and development of cardiovascular diseases (CVDs). However, the molecular mechanisms underlying the effects of parathyroid disorders on endothelial dysfunction and platelet aggregation, two main determinants of CVDs, are not completely understood.
Objective
This work aimed to evaluate the effects of PHPT and HypoPT on oxidative stress and endothelial and platelet function.
Methods
This monocentric cross-sectional study at an outpatient clinic included 40 individuals with HypoPT, 40 with PHPT, and 40 age- and sex-matched control participants. Main outcome measures included circulating levels of markers of oxidative stress, endothelial function, and platelet activation, calcium metabolism parameters, flow-mediated vasodilation (FMD), and carotid intimal-media thickness (IMT).
Results
HypoPT and PHPT patients showed increased oxidative stress markers as compared to control participants (P < .001). Among patients with parathyroid disorders, those with PHPT demonstrated the highest reduction of nitric oxide (P < .001 vs HypoPT and controls) and FMD (P < .001 and P = .001) and a marked increase of IMT (P < .001 and P = .001). We also observed an increased platelet aggregation in patients with parathyroid disorders, with the highest values in PHPT patients (P < .001, PHPT vs controls; P = .006, HypoPT vs controls; P < .001, PHPT vs HypoPT), along with increased levels of soluble P selectin and thromboxane B2.
Conclusion
PHPT and HypoPT patients have increased markers of atherothrombotic risk due to endothelial and platelet function alterations. Our results suggests that parathyroid hormone may influence platelet reactivity. Further research is needed to determine if personalized antiplatelet therapy is necessary in individuals with parathyroid disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome 00128, Italy.
- Department of Medicine, Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome 00128, Italy.
- Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico of Rome, Rome 00128, Italy.
- Unit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome 00128, Italy.
- Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina 04100, Italy.
- IRCCS Neuromed, Pozzilli 86077, Italy.
ORCID-Profile: Annunziata Nusca, Andrea Palermo, Roberto Carnevale, Francesco Grigioni
Förderung
- Società Italiana dell'Osteoporosi
- Italian Ministry of Health
- Società Italiana dell’Osteoporosi
Zitieren
APA
Naciu, A. M., Nusca, A., Palermo, A., Piccirillo, F., Tabacco, G., D'Amico, A., Di Tommaso, A. M., Sterpetti, G., Viscusi, M. M., Bernardini, F., Forte, M., D'Ambrosio, L., Frati, G., Nocella, C., Napoli, N., Carnevale, R., Sciarretta, S., & Grigioni, F. (2025). Platelet Function and Markers of Atherothrombotic Risk in Individuals With Parathyroid Disorders. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf138
Vancouver
Naciu AM, Nusca A, Palermo A, Piccirillo F, Tabacco G, D'Amico A, et al. Platelet Function and Markers of Atherothrombotic Risk in Individuals With Parathyroid Disorders. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf138
BibTeX
@article{Naciu2025,
author = {Naciu, Anda Mihaela and Nusca, Annunziata and Palermo, Andrea and Piccirillo, Francesco and Tabacco, Gaia and D'Amico, Alessandra and Di Tommaso, Alfonso Maria and Sterpetti, Giulia and Viscusi, Michele Mattia and Bernardini, Federico and Forte, Maurizio and D'Ambrosio, Luca and Frati, Giacomo and Nocella, Cristina and Napoli, Nicola and Carnevale, Roberto and Sciarretta, Sebastiano and Grigioni, Francesco},
title = {Platelet Function and Markers of Atherothrombotic Risk in Individuals With Parathyroid Disorders},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf138}
}
EUVIMED